These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6193345)

  • 1. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects of bretylium on canine ventricular muscle during acute ischemia and reperfusion.
    Fujimoto T; Hamamoto H; Peter T; McCullen A; McCullen A; Melvin N; Mandel WJ
    Am Heart J; 1983 Jun; 105(6):966-72. PubMed ID: 6858845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
    Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E; Gibson JK
    Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium.
    Coker SJ
    J Pharmacol Methods; 1989 Jul; 21(4):263-79. PubMed ID: 2755145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
    Inoue H; Toda I; Nozaki A; Matsuo H; Sugimoto T
    Cardiovasc Res; 1985 Oct; 19(10):655-60. PubMed ID: 4053141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane action and catecholamine release action of bretylium tosylate in normoxic and hypoxic canine Purkinje fibers.
    Nishimura M; Watanabe Y
    J Am Coll Cardiol; 1983 Aug; 2(2):287-95. PubMed ID: 6863763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic and antiarrhythmic effects of phentolamine in experimental coronary artery occlusion and reperfusion in the dog.
    Stewart JR; Burmeister WE; Burmeister J; Lucchesi BR
    J Cardiovasc Pharmacol; 1980; 2(1):77-91. PubMed ID: 6154207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bretylium tosylate on ventricular fibrillation threshold during hypothermia in dogs.
    Bjørnstad H; Mortensen E; Sager G; Refsum H
    Am J Emerg Med; 1994 Jul; 12(4):407-12. PubMed ID: 8031422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
    Patterson E; Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1981 Mar; 216(3):453-8. PubMed ID: 7205624
    [No Abstract]   [Full Text] [Related]  

  • 14. ELectrophysiologic properties of bretylium tosylate on atrial myocardium.
    Mirro MJ; Webel RR; Kelly KJ; Grina LA
    J Cardiovasc Pharmacol; 1981; 3(6):1312-20. PubMed ID: 6173532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the electrophysiological properties of bretylium tosylate in man].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 May; 69(5):503-11. PubMed ID: 821420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.
    Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F
    Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects of coronary occlusion and reperfusion. Observations of dispersion of refractoriness and ventricular automaticity.
    Levites R; Banka VS; Helfant RH
    Circulation; 1975 Nov; 52(5):760-5. PubMed ID: 1175258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bretylium on cardiovascular changes induced by coronary occlusion in the cat.
    Corr PB; Gillis RA
    Eur J Pharmacol; 1975; 33(2):401-4. PubMed ID: 1183484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J
    Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study.
    Koo CC; Allen JD; Pantridge JF
    Cardiovasc Res; 1984 Dec; 18(12):762-7. PubMed ID: 6518459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.